We have continued to focus on the role of insulin-like growth factors (IGFs) and tumor specific translocations in the pathogenesis of pediatric sarcomas, specifically rhabdomyosarcomas (RMS), Ewings sarcomas/PNET (Ewings family of tumors EFT), and osteogenic sarcomas (OS). We have recently confirmed that the fusion protein PAX3-FKHR generated by the tumor specific translocation of alveolar RMS leads to overexpression of IGF2 and an IGF binding protein (IGFBP-5) critical for IGF signaling. We have determined that the mechanism of PAX3-FKHR induced increase in IGF2 expression is indirect, since there is no evidence of direct binding to the region of the IGF2 promoter that is positively regulated by co-transfection studies. The mechanism and effect of increased IGFBP-5 expression due to PAX3-FKHR is currently under investigation. We have continued to utilize C2 mouse myoblasts overexpressing IGF2 to determine specific consequences of IGF2 overexpression in a muscle background. We have identified cabonic anhydrase 6 as overexpressed in C2 cells overexpressing IGF2 and are currently working to determine the significance of this finding. We are hoping to further analyze C2 cells with high IGF2 expression compared to normal C2 cells using cDNA microarray analysis. Recently, we have confirmed the overexpression of acetylcholine receptor gamma subunit in human rhabdomyosarcomas and are working to determine whether this can be exploited clinically. Finally, we are beginning to collaborate on a genetic model of rhabdomyosarcoma in mice, and have found that this model predicts abnormalities in the p16-CDK-4-cylcin D-Rb pathway in these tumors and have confirmed such abnormalities in human tumor specimens. We have now firmly established a mouse orthotopic model of osteosarcoma with spontaneous metastases, and are using cDNA microarray analyses to identify genetic determinants of metastasis in this model. We also continue to explore the potential role of combining growth hormone inhibition with chemotherapy in canine osteosarcoma, studying the hypothesis that lowering IGFI levels prior to cytotoxic chemotherapy will lead to increased apoptosis in tumor tissue dependent on IGFI for survival. - cell cycle, IGF-I receptor, IGF-I, IGF-2, Ewing's sarcoma family of tumors (ESFT), rhabdomyosarcoma, - Human Subjects: Minor under 18 Years Old & Human Tissues, Fluids, Cells, etc.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC006892-11
Application #
6290784
Study Section
Special Emphasis Panel (POB)
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Kim, Su Young; Lee, Chih Hung; Midura, Brieanne V et al. (2008) Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 25:201-11
Mackall, Crystal L; Rhee, Eunice H; Read, Elizabeth J et al. (2008) A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas. Clin Cancer Res 14:4850-8
Wan, X; Harkavy, B; Shen, N et al. (2007) Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26:1932-40
Petricoin 3rd, Emanuel F; Espina, Virginia; Araujo, Robyn P et al. (2007) Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res 67:3431-40
Merchant, Melinda S; Melchionda, Fraia; Sinha, Manoj et al. (2007) Immune reconstitution prevents metastatic recurrence of murine osteosarcoma. Cancer Immunol Immunother 56:1037-46
van den Broeke, Leon T; Pendleton, C David; Mackall, Crystal et al. (2006) Identification and epitope enhancement of a PAX-FKHR fusion protein breakpoint epitope in alveolar rhabdomyosarcoma cells created by a tumorigenic chromosomal translocation inducing CTL capable of lysing human tumors. Cancer Res 66:1818-23
Wan, Xiaolin; Shen, Na; Mendoza, Arnulfo et al. (2006) CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling. Neoplasia 8:394-401
Terabe, Masaki; Khanna, Chand; Bose, Seuli et al. (2006) CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta. Cancer Res 66:3869-75
Krishnan, Kartik; Khanna, Chand; Helman, Lee J (2006) The molecular biology of pulmonary metastasis. Thorac Surg Clin 16:115-24
Khanna, Chand; Helman, Lee J (2006) Molecular approaches in pediatric oncology. Annu Rev Med 57:83-97

Showing the most recent 10 out of 19 publications